Head-to-head · WeighScore
EdgeRx vs Onyx Weight Loss
By GLP-1 ScorecardUpdated
Score comparison
EdgeRx has the higher recorded score — 79/100 to 58.8/100.
EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EdgeRx lists compounded GLP-1 injections in a men’s health program. Its terms say the final charge can vary with the prescription and pharmacy.
Before you choose
Onyx Weight Loss does not publish a semaglutide price, so its Onyx Weight Loss review sets out what it does disclose, while the EdgeRx review explains the conditions attached to EdgeRx's figure. The semaglutide cost page compares published rates across the field. Ask Onyx Weight Loss for a written total before treating either one as the cheaper choice.
If neither one fits, EdgeRx vs Peak Wellness and Elara Health and Wellness vs Onyx Weight Loss compare each of them with another graded program, and the list of alternatives to EdgeRx ranks the programs closest to EdgeRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | EdgeRx | Onyx Weight Loss |
|---|---|---|
| WeighScore | 79/100 | 58.8/100 |
| Grade | C+ | C |
| Site position | #42 | #392 |
| Semaglutide | Advertised $199/mo; confirm final prescription charge | Not disclosed by drug |
| Tirzepatide | Advertised $225/mo; confirm final prescription charge | Not disclosed by drug |
| Coverage | 47 states advertised; excludes Arkansas, Indiana and South Carolina | 9 states listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Yes |
Strengths
- Publishes separate semaglutide and tirzepatide prices
- Names Strive as its primary 503A pharmacy in its terms
- Advertises included shipping and physician review
What to consider
- The final charge may vary with the prescribed product and dispensing pharmacy
- The homepage’s approval refund language needs to be reconciled with the consultation fee and final-sale terms
Strengths
- Monthly injection plans list medication, required labs, follow-ups, shipping and supplies
- Ten-week options publish a different follow-up schedule
What to consider
- Public plan cards do not name the specific drug
- Confirm the dispensing pharmacy, renewal and refund terms before ordering
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.